Avascular Necrosis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2028

  • Single User License $3500

Avascular Necrosis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2028

Status : August, 2020 | Pharmaceutical | PPT format

Report Digest


Avascular Necrosis Market: Overview

Avascular necrosis (AVN) also named as aseptic necrosis, osteonecrosis, or ischemic bone necrosis, is a condition bringing about the death of bone cells because of lack of blood supply. It frequently leads fall of the joint surface and consequent joint inflammation because of an irregular joint surface. Avascular necrosis influences the closures (epiphysis) of long bones, for example, upper humerus, femur, and bones of lower leg joint. Normally it occurs because of combination of different factors including genetic, metabolic, increased consumption of alcohol, smoking, and different ailments.

Usually, in order to treat avascular necrosis, the nonsurgical treatment methods are used, for example, changes in daily activities, anti-inflammatory medications, and crutches are the major source of treatment to help in reducing the progress of the disease and in pain relief. Surgical treatment comprise cartilage and bone grafting, core decompression, and entire hip replacement. On the basis of the cause, avascular necrosis is categorized into non-traumatic and traumatic avascular necrosis.

Avascular Necrosis Market: Trends and Opportunities

Increased consumption of alcohol for a long time, heavy dose of systematic corticosteroid utilize are the significant hazard factors for avascular necrosis.

Other serious factors or conditions related with non-traumatic osteonecrosis incorporate cancer, autoimmune illness, Gaucher disorder, decompression illness (Caisson ailment), HIV infection, pancreatitis, and blood issue, for example, sickle cell infection. Certain treatment including chemotherapy and radiation treatment can cause osteonecrosis as well. Besides, individuals who have experienced organ transplants are at high risk of osteonecrosis.

Advanced technologies related to treatments for avascular necrosis, for example, Advanced Therapy Medicinal Products (ATMPs) is likely to help avascular necrosis market. Advanced Therapy Medicinal Products is a class of advanced treatments that includes quality treatment, physical cell treatment, and tissue-engineered products.

Increased expense of surgical treatments and delayed diagnosis because of asymptomatic nature of this condition at beginning are the major hindering factors for avascular necrosis market development.

Avascular Necrosis Market: Market Potential

Creators evaluated the long term clinical result and implant survivorship of patients that experienced unicompartmental knee arthroplasty (UKA) for knee avascular necrosis. They reflectively investigated 29 back to back UKA carried out by two senior specialists in 28 patients with unicompartmental avascular necrosis of the knee (AVN) somewhere during 1989 and 2001. In the longest span till date, discoveries proposed a association of UKA for treatment of AVN with increased survival rates and stable clinical enhancement. With the end goal to treat patients with unicompartmental osteonecrosis of the knee, UKA is a productive alternative.

Avascular Necrosis Market: Regional Outlook

North America is foreseen to develop a noteworthy revenue in global avascular necrosis market in the forthcoming years because of rising prevalence of avascular necrosis and earlier Food and Drug Administration (FDA) consent for the new avascular necrosis medications in the region.

Moreover, Asia Pacific avascular necrosis market is as well foreseen to anticipate most elevated development during coming years, inferable from rise in development activities for the treatment of avascular necrosis by various key players in the region.

Avascular Necrosis Market: Competitive Landscape

Major players operating in the global avascular necrosis market are Boehringer Ingelheim GmbH, Bone Therapeutics, Bayer AG, Ethicon Inc., Enzo Biochem Inc., Eli Lilly and Company, Integra LifeSciences Corporation, Grifols SA, K-Stemcell Co Ltd., Merck KGaA, Medtronic Plc, Pfizer Inc., Stryker Corporation, Sanofi SA, Zimmer Biomet Holdings, and Wright Medical Group N.V.

The study presents a granular assessment and quantitative evaluation of:

  • Key growth factors and prominent trends
  • Size and share of key segments in overall market
  • Key challenges and winning imperatives
  • Factors shaping competitive landscape
  • Insights into how contours of market will change in coming years
  • Technological advances
  • New avenues and imminent investment pockets
  • Regulatory landscape shaping current and future strategies of companies

The region-wise assessment includes market dynamics in:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study is prepared with the help of an extensive primary and secondary research. Primary research includes but not limited to interactions, interviews, surveys, and events. Opinions of policy makers and industry experts are carefully integrated into the insights to complement primary research. Volumes of secondary data gleaned through renowned paid sources, annual statements, reputed journals, and government documents offer insights into current dynamics and key evolution trajectories the market is likely to assume. The research employs various industry-wide analytics methods and well-established methodologies to ascertain the attractiveness of key segments. Further, it evaluates the lucrativeness of key regions and factors underlying their maturity. The insights notably include a detailed analysis of forces behind vendor differentiation and offers insight into investment-decision making by prominent players.

The report strives to enlighten businesses and industry stakeholders on multiple facets of the growth dynamic of the market, the key of which include answers to:

  • Which key factors will shape the competitive landscape?
  • Which trends will stimulate research and development activities in different geographies?
  • Which are the lucrative growth areas and what is the size of potential they are likely contribute to the overall market?
  • Which disruptions in market growth are likely to come with the new business models?
  • Which are some of the recent overhauls in policies that may change the course of the market significantly?
  • Which are the geographies that will form sizable sources of new streams to new and established players alike?
  • How are top players likely to realign their strategy to counter the forces of competition?
  • Which key strategies emerging players are likely to focus on to consolidate their position?
  • Which changes in end-user preferences might affect the status quo held by the leading players?
  • Which are some of the game-changing innovations influencing the projected share and revenue of the market and its segments?

Note: Utmost care has invariably been taken to present data and arrive at statistics at all the TMR Research reports. Meanwhile, some recent developments and new industry trends may take time to be included in the reports.